Cargando…
Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy
BACKGROUND: Peanut allergy has become an important public health issue. It can be the cause of severe reactions and also the trigger of significant anxiety for the allergic individual, especially with regards to the risk of unintentional accidental exposures. Peanut oral immunotherapy (POIT) is a ne...
Autores principales: | Blackman, Andrea C., Anagnostou, Aikaterini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712748/ https://www.ncbi.nlm.nih.gov/pubmed/31489399 http://dx.doi.org/10.1177/2515135519869763 |
Ejemplares similares
-
Insights into Microbiome and Metabolic Signatures of Children Undergoing Peanut Oral Immunotherapy
por: Blackman, Andrea C., et al.
Publicado: (2022) -
A Practical, Stepwise Approach to Peanut Oral Immunotherapy in Clinical Practice: Benefits and Risks
por: Anagnostou, Aikaterini
Publicado: (2021) -
Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014) -
Children and caregiver proxy quality of life from peanut oral immunotherapy trials
por: Galvin, Audrey Dunn, et al.
Publicado: (2022) -
Qualitative interviews to understand health care providers’ experiences of prescribing licensed peanut oral immunotherapy
por: Anagnostou, Aikaterini, et al.
Publicado: (2022)